ArticleFrontiers in pharmacology2026
International expert perspectives on pharmacogenomics in pharmacy education: a qualitative study with implications for South Africa.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pharmacogenomics (PGx) has the potential to transform healthcare in South Africa through the delivery of precision medicine. However, the successful implementation of PGx services depends on a healthcare workforce equipped with appropriate PGx competencies. Given pharmacists' central role in medication management, they are key members of the PGx team and require targeted education to support PGx-guided clinical decision-making. Insights from international experts can inform the development of pharmacy curricula, strengthening pharmacists' capacity to facilitate PGx implementation within local healthcare systems. Method: A qualitative study design was used to explore international experts' perspectives on the inclusion of PGx in pharmacy education. Health professional experts in PGx across the globe, including pharmacists from community and hospital settings, medical doctors, researchers, and clinical pharmacologists, were purposively sampled to participate in semi-structured interviews. The interviews explored views on PGx practices, the role of higher-education institutions and professional societies, and recommendations for PGx education across undergraduate, postgraduate, and continuing professional development pathways. Result: Twenty experts representing 12 countries were interviewed. Three overarching themes were identified: (1) PGx competency for pharmacists, (2) approaches to PGx education, and (3) barriers to PGx education. Subthemes included the evolving professional role of pharmacists in PGx, the knowledge and skills required for competent practice, and the distinction between foundational and advanced levels of PGx proficiency. Additional sub-themes addressed core PGx curricular content, effective instructional and assessment strategies, the role of community and stakeholder engagement, considerations regarding the appropriate depth, and integration of PGx material within pharmacy curricula. Conclusion: Experts internationally emphasized that PGx should be established as a core competency for all pharmacists. Pharmacists with both foundational and applied PGx competencies are well-positioned to contribute meaningfully to the clinical integration and advancement of PGx services. A longitudinal, integrated educational approach delivered by academics and health professionals with PGx expertise was viewed as essential for preparing students to apply PGx principles effectively in real-world practice. For South Africa, coordinated collaboration among higher education institutions, healthcare organizations, and professional regulatory bodies will be critical to embedding PGx within pharmacy education and advancing national precision-medicine goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.